Results 11 to 20 of about 67,397 (310)

Hypercalcemia of malignancy: An update on pathogenesis and management

North American Journal of Medical Sciences, 2015
Hypercalcemia of malignancy is a common finding typically found in patients with advanced stage cancers. We aimed to provide an updated review on the etiology, pathogenesis, clinical presentation, and management of malignancy-related hypercalcemia.
Aibek E Mirrakhimov
exaly   +2 more sources

Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment

Endocrine Reviews, 2016
Rajiv Kumar
exaly   +2 more sources

Familial hypocalciuric hypercalcemia and related disorders

Best Practice and Research in Clinical Endocrinology and Metabolism, 2018
Janet Y Lee, Dolores M Shoback
exaly   +2 more sources

Low-trauma Fracture with Hypercalcemia: Need to Look Deeper [PDF]

Bengal Physician Journal, 2022
Aim: To emphasize the importance of a timely, systemic approach to hypercalcemia to reach an etiological diagnosis. Background: Hypercalcemia is commonly encountered in many individuals, in both inpatient and outpatient settings.
Aditya Deshpande, Pankaj Singhania, Sreejith Babu, Anish Kar, Pranab K Sahana, Rana Bhattacharjee   +5 more
doaj   +1 more source

A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia

Medical Science Monitor, 2022
Calcium is the most abundant extracellular cation in the body, and it is responsible for structural and enzymatic functions. Calcium homeostasis is regulated by 3 factors: calcitonin, vitamin D, and parathyroid hormone (PTH).
C. Tonon, Taline Alisson Artemis Lazzarin Silva, F. Pereira, D. Queiroz, Edson Luiz Favero Júnior, Danilo Martins, P. Azevedo, M. Okoshi, L. Zornoff, S. D. de Paiva, M. Minicucci, B. Polegato   +11 more
semanticscholar   +1 more source

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.

Journal of Clinical Endocrinology and Metabolism, 2022
BACKGROUND Hypercalcemia of malignancy (HCM) is the most common metabolic complication of malignancies, but its incidence may be declining due to potent chemotherapeutic agents.
G. E. Fuleihan, G. Clines, Mimi I Hu, C. Marcocci, M. Murad, Thomas Piggott, C. V. Van Poznak, Joy Y Wu, M. Drake   +8 more
semanticscholar   +1 more source

Hypercalcemia in Pregnancy Due to CYP24A1 Mutations: Case Report and Review of the Literature

Nutrients, 2022
Pathogenic mutations of CYP24A1 lead to an impaired catabolism of vitamin D metabolites and should be considered in the differential diagnosis of hypercalcemia with low parathyroid hormone concentrations.
S. Pilz, V. Theiler-Schwetz, P. Płudowski, S. Zelzer, A. Meinitzer, S. Karras, W. Misiorowski, A. Zittermann, W. März, C. Trummer   +9 more
semanticscholar   +1 more source

Rare Causes of Hypercalcemia: 2021 Update.

Journal of Clinical Endocrinology and Metabolism, 2021
CONTEXT Primary hyperparathyroidism and malignancy are the etiologies in 90% of cases of hypercalcemia. When these entities are not the etiology of hypercalcemia, uncommon conditions need to be considered.
Y. Motlaghzadeh, J. Bilezikian, D. Sellmeyer   +2 more
semanticscholar   +1 more source

Steroid responsive idiopathic calcitriol induced hypercalcemia: a case report and review of the literature

BMC Nephrology, 2023
Background Idiopathic Calcitriol Induced Hypercalcemia is a rare cause of a common condition of hypercalcemia. Hypercalcemia is most commonly the result of hyperparathyroidism and together with hypercalcemia of malignancy accounts for over 95% of cases ...
Omar El Fadel, Anshel Kenkare, Jingjing Zhang   +2 more
doaj   +1 more source

Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia

Cureus, 2021
Calcium (Ca+2) is a divalent cation that plays a critical role in numerous body functions such as skeletal mineralization, signal transduction, nerve conduction, muscle contraction, and blood coagulation. Ca+2 metabolism is linked to magnesium (Mg+2) and
M. Tinawi
semanticscholar   +1 more source